Top

Published in:

Open Access 01-08-2016 | Review Article

A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis

Authors: Jayanta M. Barua, Ignacio Arance, Javier C. Angulo, Claus R. Riedl

Published in: International Urogynecology Journal | Issue 8/2016

Abstract

Bladder pain syndrome/interstitial cystitis (BPS/IC) is a chronic disease characterised by persistent irritating micturition symptoms and pain. The objective was to compare the clinical efficacy of currently available products for intravesical therapy of BPS/IC and to assess their pharmacoeconomic impact. A Pubmed/Medline database search was performed for articles on intravesical therapy for BPS/IC. A total of 345 publications were identified, from which 326 were excluded. Statistical evaluation was performed with effect size (ES) assessment of symptom reduction and response rates. The final set of 19 articles on intravesical BPS/IC therapy included 5 prospective controlled trials (CTs), the remaining were classified as uncontrolled clinical studies. The total number of patients included was 801, 228 of whom had been evaluated in a CT. For CTs, the largest ES for symptom reduction as well as response rate was observed for high molecular weight hyaluronic acid (HMW-HA), with similar findings in two uncontrolled studies with HMW-HA. The number needed to treat to achieve a response to intravesical therapy was 2.67 for intravesical pentosan polysulphate and 1.31 for HMW-HA which were superior to all other instillates. HMW-HA was significantly superior in cost effectiveness and cost efficacy to all other instillation regimes. The present meta-analysis combined medical and pharmacoeconomic aspects and demonstrated an advantage of HMW-HA over other instillation agents; however, direct comparisons between the different products have not been performed to date in properly designed controlled studies.

Hanno P, Dmochowski R (2009) Status of international consensus on interstitial cystitis/bladder pain syndrome: 2008 snapshot. Neurourol Urodyn 28:274–286CrossRefPubMed

Hurst RE, Roy JB, Min KW, Veltri RW, Marley G, Patton K, Shackelford DL, Stein P, Parsons CL (1996) A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology 48:817–821CrossRefPubMed

Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145:732–735PubMed

Parsons CL (1996) Potassium sensitivity test. Tech Urol 2:171–173PubMed

Daha LK, Riedl CR, Hohlbrugger G, Knoll M, Engelhardt PF, Pflüger H (2003) Comparative assessment of maximal bladder capacity, 0.9% NaCl vs. 0.2 M KCl, for the diagnosis of interstitial cystitis: a prospective controlled study. J Urol 170:807–809CrossRefPubMed

Daha KL, Riedl CR, Lazar D, Simak R, Pflüger H (2008) Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome/interstitial cystitis, bladder capacity and potassium sensitivity. Scand J Urol 8:1–4

Madersbacher H, van Ophoven A, van Kerrebroeck PEVA (2013) GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans—a review. Neurourol Urodyn 32:9–18CrossRefPubMed

Von Heyden B, Schmid HP (2000) Intravesical therapy of interstitial cystitis. Urologe A 39:542–544CrossRef

Rovner E, Propert KJ, Bresinger C, Wein AJ, Foy M, Kirkemo A et al (2000) Treatment used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology 26:940–945CrossRef

10.

Burkman RT (2004) Chronic pelvic pain of bladder origin: epidemiology, pathogenesis and quality of life. J Reprod Med 49:225–229PubMed

11.

Nickel JC, Moldwin R, Lee S, Davis EL, Henry RA, Wyllie MG (2009) Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 103:910–918CrossRefPubMed

12.

Parkin J, Shea C, Sant GR (1997) Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis—a practical approach. Urology 49:105–107CrossRefPubMed

13.

Fall M, Oberpenning F, Peeker R (2008) Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions? Eur Urol 54:65–75CrossRefPubMed

14.

Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefPubMedPubMedCentral

15.

Morales A, Emerson L, Nickel J, Lundie M (1996) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156:445–448CrossRef

16.

Riedl C, Engelhardt P, Daha K, Moraskis N, Pfluger H (2008) Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int Urogynecol J 19:717–721CrossRef

17.

Daha LK, Lazar D, Simak R, Pfluger H (2008) The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with BPS/IC: preliminary results. Int Urogynecol J 19:987–990CrossRef

18.

Cohen J (1988) Statistical power analysis for the behavioural sciences, 2nd edn. Erlbaum, Hillsdale

19.

Lv YS, Zhou HL, Mao HP, Gao R, Wang YD, Xue XY (2012) Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis. Int Urogynecol J 23:1715–1720CrossRefPubMed

20.

Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pfluger H (2005) Do cystometric findings predict the results of Intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol 47:393–397CrossRefPubMed

21.

Hung MJ, Chen YT, Shen PS, Hsu ST, Chen GD, Ho ESC (2012) Risk factors that affect the treatment of interstitial cystitis using intravesical therapy with a dimethyl sulfoxide cocktail. Int Urogynecol J 23:1533–1539CrossRefPubMed

22.

Gafni-Kane A, Botros SM, Du H (2013) Measuring the success of combined intravesical dimethylsulfoxide and triamcinolone for treatment of bladder pain syndrome/interstitial cystitis. Int Urogynecol J 24:303–311CrossRefPubMed

23.

Cervigni M, Natale F, Nasta L, Padoa A, Lo Voi R, Porru D (2008) A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis. Int Urogynecol J 19:943–947CrossRef

24.

Porru D, Cervigni M, Nasta L, Natale F, Lo Voi R, Tinelli C et al (2008) Results of endovesical hyaluronic acid/chondroitin sulfate in the treatment of interstitial cystitis/painful bladder syndrome. Rev Recent Clin Trials 3:126–129CrossRefPubMed

25.

Gauruder-Burmester A, Wildt B, Tunn R (2006) Treatment of overactive bladder with sodium chondroitin sulphate. Zentralbl Gynakol 128:336–340CrossRefPubMed

26.

Gauruder-Burmester A, Popken G (2009) Follow-up at 24 months after treatment of overactive bladder with 0.2% sodium chondroitin sulfate. Aktuelle Urol 40:355–359CrossRefPubMed

27.

Hazewinkel MH, Stalpers LJA, Dijkgraaf MG, Roovers JWR (2011) Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies. Int Urogynecol J 22:725–730CrossRefPubMedPubMedCentral

28.

Parsons CL (2005) Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 65:45–48CrossRefPubMed

29.

Parsons CL, Zupkas P, Proctor J, Koziol J, Franklin A, Giesing D et al (2012) Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis. J Sex Med 9:207–212CrossRefPubMed

30.

Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa R, Usai E (1997) Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59:26–29CrossRefPubMed

31.

Figuereido AB, Palma P, Riccetto C, Hermann V, Dambros M, Capmartin R (2011) Clinical and urodynamic experience with intravesical hyaluronic acid in painful bladder syndrome associated with interstitial cystitis. Actas Urol Esp 35:184–187

32.

Cervigni M, Natale F, Nasta L, Mako A (2012) Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results. Int Urogynecol J 23:1187–1192CrossRefPubMed

33.

Sorensen RB (1996) Chondroitin sulphate in the treatment of interstitial cystitis and chronic inflammatory disease of the urinary bladder. Eur Urol 2:16–18CrossRef

34.

Shao Y, Shen ZJ, Rui WB, Zhou WL (2010) Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology 75:547–550CrossRefPubMed

35.

Nickel JC, Egerdie B, Steinhoff G, Palmer B, Hanno P (2010) A multicenter, randomized, double-blind, and parallel groups: pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with IC/PBS. Urology 76:804–809CrossRefPubMed

36.

Nickel JC, Hanno P, Kumar K, Thomas H (2012) Effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. Urology 79:1220–1224CrossRefPubMed

37.

Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJA (1997) A placebo-controlled study of intravesical pentosan polysulphate for the treatment of interstitial cystitis. Br J Urol 79:168–171CrossRefPubMed

38.

Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ (2008) Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 179:177–185CrossRefPubMed

39.

Sairanen J, Leppilahti M, Tammela TLJ, Paananen I, Aaltomaa S, Taari K, Ruutu M (2009) Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on interstitial cystitis? Scand J Urol Nephrol 43:212–219CrossRefPubMed

40.

Engelhardt PF, Morakis N, Daha LK, Esterbauer B, Riedl CR (2011) Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J 22:401–405CrossRefPubMed

41.

Lai MC, Kuo YC, Kuo HC (2013) Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome. A comparative randomized assessment of different regimens. Int J Urol 20:203–207CrossRefPubMed

42.

Kallestrup E, Jorgensen S, Nordling J, Hald H (2005) Treatment of interstitial cystitis with Cystistat®: a hyaluronic acid product. Scand J Urol Nephrol 39:143–147CrossRefPubMed

43.

Gupta SK, Pidcock L, Parr NJ (2005) The potassium sensitivity test: a predictor of treatment response in interstitial cystitis. BJU Int 96:1063–1066CrossRefPubMed

44.

Steinhoff G (2003) The efficacy of chondroitin sulphate in treating interstitial cystitis. Eur Urol Suppl 2:14–16CrossRef

45.

Nordling J, van Ophoven A (2008) Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial. Arzneitmittelforschung 58:328–335

46.

Nickel J, Egerdie B, Downey J, Singh R, Skehan A, Carr L, Irvine-Bird K (2008) A real-life multicenter clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int 103:56–60CrossRefPubMed

47.

Porru D, Leva F, Parmigiani A, Barletta D, Choussos D, Gardella B et al (2011) Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int Urogynecol J 23:1193–1199CrossRefPubMed

48.

Bade JJ, Mensink HJ, Laseur M (1995) Intravesical treatment of interstitial cystitis with a heparin analogue. Br J Urol 75:260PubMed

49.

Giannantoni A, Bini V, Dmochowski R, Hanno P, Nickel JC, Proietti S, Wyndaele JJ (2012) Contemporary management of the painful bladder: a systematic review. Eur Urol 61:29–53CrossRefPubMed

50.

Matsuoka PK, Hadda JM, Pacetta AM, Baracat EC (2012) Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J 23:1147–1153CrossRefPubMed

Title: A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis
Authors: Jayanta M. Barua
Ignacio Arance
Javier C. Angulo
Claus R. Riedl
Publication date: 01-08-2016
Publisher: Springer London
Published in: International Urogynecology Journal / Issue 8/2016
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-015-2890-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2016

Incidence of successful voiding and predictors of early voiding dysfunction after retropubic sling

Natural history of pessary use in women aged 65 – 74 versus 75 years and older with pelvic organ prolapse: a 12-year study

Letter to the Editor regarding: “Treatment patterns and survival outcomes in patients with cervical cancer complicated by complete uterine prolapse: a systematic review of literature”

Urogynecology digest

German translation and validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire–IUGA revised (PISQ-IR)

Voiding trial outcome following pelvic floor repair without incontinence procedures